Healthtech Investors & VC Firms in North America

426 firms in this list, with a median first check of $540K. 114 of them lead rounds. Generated from verified public data and updated continuously.

Fund	FoxScore	HQ	Invests	Stage	Check	CRM
AN Anthropy Partners BPBFCBGF6 people	88🔒	Seattle	US	Seed–Series A	—	+ Add to CRM
BE Beltrae Partners CMGHIKJM9 people	88🔒	Belfast	GB	Seed–Growth	$1M – $15M	+ Add to CRM
PI Pivotal Life Sciences AVBMGBJL12 people	88🔒	San Francisco	US	Seed–Late Stage	—	+ Add to CRM
TA TA Ventures VTAVOMRA9 people · Leads rounds	88🔒	Frankfurt am Main	DE	Pre-Seed–Series A	$100K – $1M	+ Add to CRM
EV Evidity Health Capital ASPELAAL5 people	88🔒	New York	US	Growth–Late Stage	$5M	+ Add to CRM
GR Great North Ventures RWRWGGJD15 people · Leads rounds	88🔒	Maple Grove	US	Seed–Series A	—	+ Add to CRM
OV Oval Park Capital JWESPG3 people · Leads rounds	88🔒	Raleigh	US	Seed–Late Stage	$500K – $1.5M	+ Add to CRM
SE Selva Ventures KDDWMGRP6 people · Leads rounds	88🔒	Los Angeles	US	Seed–Series A	$100K – $5M	+ Add to CRM
FI First Ascent Ventures RBTVJDTS7 people · Leads rounds	88🔒	Toronto	CA	Series A–Late Stage	$3.6M – $7.3M	+ Add to CRM
RE Red River West AVABLBOH7 people · Leads rounds	88🔒	Paris, Ile-De-France	FR	Seed–Growth	$5.4M – $54M	+ Add to CRM
PA Pace Ventures MSGMLN3 people · Leads rounds	88🔒	Berlin	DE	Pre-Seed–Series A	$550K – $1.6M	+ Add to CRM
AI AI Capital JSNTECSS11 people	88🔒	Denver	US	Series A–Growth	—	+ Add to CRM
TH Third Act Ventures MZ1 person	88🔒	San Diego	US	Seed	—	+ Add to CRM
EN Endeavour Vision DTASFPSM6 people	88🔒	Geneva	CH	Late Stage	—	+ Add to CRM
ES Esplanade Ventures SESMESAN11 people · Leads rounds	88🔒	Toronto	CA	Pre-Seed–Series B	—	+ Add to CRM
FI Finchley Healthcare Ventures DGMGPBCC11 people	88🔒	Montreal	CA	Seed–Late Stage	—	+ Add to CRM
H H Venture Partners EEBB2 people · Follows rounds	88🔒	Cincinnati	US	Seed–Late Stage	$250K – $5M	+ Add to CRM
MC MC Healthcare Ventures JMSO2 people	88🔒	Cambridge	US	Seed–Series A	—	+ Add to CRM
JO Joint Effects TVJH2 people	88🔒	Boston	US	—	—	+ Add to CRM
IN Intelligence Ventures DNLLJBMY6 people	88🔒	—		Pre-Seed–Seed	$50K – $50K	+ Add to CRM
PR Primer Sazze Partners DGGKIPKL7 people · Follows rounds	88🔒	Seoul	KR	Pre-Seed–Series A	$500K – $3M	+ Add to CRM
SP Spring Impact Capital KIGDOHLS10 people	88🔒	Vancouver	CA	Pre-Seed–Series A	—	+ Add to CRM
IN Inflexion DW1 person · Leads rounds	88🔒	London	GB	Series B–Growth	$1.1B	+ Add to CRM
HC HCS Capital AHAMHBJE7 people	88🔒	Miami	US	Seed–Late Stage	—	+ Add to CRM

Anthropy Partners

SeattleSeed–Series A

BPBFCBGF6 people

Beltrae Partners

BelfastSeed–Growth$1M – $15M

CMGHIKJM9 people

Pivotal Life Sciences

San FranciscoSeed–Late Stage

AVBMGBJL12 people

TA Ventures

Frankfurt am MainPre-Seed–Series A$100K – $1M

VTAVOMRA9 people

Evidity Health Capital

New YorkGrowth–Late Stage$5M

ASPELAAL5 people

Great North Ventures

Maple GroveSeed–Series A

RWRWGGJD15 people

Oval Park Capital

RaleighSeed–Late Stage$500K – $1.5M

JWESPG3 people

Selva Ventures

Los AngelesSeed–Series A$100K – $5M

KDDWMGRP6 people

First Ascent Ventures

TorontoSeries A–Late Stage$3.6M – $7.3M

RBTVJDTS7 people

Red River West

Paris, Ile-De-FranceSeed–Growth$5.4M – $54M

AVABLBOH7 people

Pace Ventures

BerlinPre-Seed–Series A$550K – $1.6M

MSGMLN3 people

AI Capital

DenverSeries A–Growth

JSNTECSS11 people

Third Act Ventures

San DiegoSeed

MZ1 person

Endeavour Vision

GenevaLate Stage

DTASFPSM6 people

Esplanade Ventures

TorontoPre-Seed–Series B

SESMESAN11 people

Finchley Healthcare Ventures

MontrealSeed–Late Stage

DGMGPBCC11 people

H Venture Partners

CincinnatiSeed–Late Stage$250K – $5M

EEBB2 people

MC Healthcare Ventures

CambridgeSeed–Series A

JMSO2 people

Joint Effects

Boston

TVJH2 people

Intelligence Ventures

Pre-Seed–Seed$50K – $50K

DNLLJBMY6 people

Primer Sazze Partners

SeoulPre-Seed–Series A$500K – $3M

DGGKIPKL7 people

Spring Impact Capital

VancouverPre-Seed–Series A

KIGDOHLS10 people

Inflexion

LondonSeries B–Growth$1.1B

DW1 person

HCS Capital

MiamiSeed–Late Stage

AHAMHBJE7 people

Data sourced from public filings and firms' own websites — see our methodology.